Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Eastern Cooperative Oncology Group
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
University of Nebraska
Adela, Inc
Jonsson Comprehensive Cancer Center
ModeX Therapeutics, An OPKO Health Company
Columbia University
Algemeen Ziekenhuis Maria Middelares
University of Modena and Reggio Emilia
Beijing Friendship Hospital